US begins probes into pharmaceutical, chip imports, setting stage for tariffs

The Trump administration is initiating investigations into pharmaceutical and semiconductor imports, potentially leading to tariffs based on national security concerns. These probes, conducted under Section 232 of the Trade Expansion Act, aim to reduce U.S. reliance on foreign drug and chip manufacturing.